Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer

Journal of Clinical Oncology

Volumn 31, Issue 4, 2013, Pages 468-474

  Yang, Limin ^a   Shen, Weidong ^b   Sakamoto, Naoko ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SIZE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROBABILITY; THYROID CANCER; TREATMENT DURATION; ADENOCARCINOMA; ADOLESCENT; AGED; CARCINOMA; CAUSE OF DEATH; CHILD; EVALUATION; MEDULLARY CARCINOMA; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; SURVIVAL RATE; THYROID TUMOR; UNITED STATES;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROBABILITY; SEER PROGRAM; SURVIVAL RATE; THYROID NEOPLASMS; UNITED STATES;

MLCS; MLOWN;

EID: 84874783657     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.4457     Document Type: Article

References (24)

1. Howlader N, Noone A, Krapcho M, et al: SEER cancer statistics review, 1975-2008, National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/ csr/1975-2008/
2. Bondeson L, Ljungberg O: Occult thyroid carcinoma at autopsy in Malmö,Sweden. Cancer 47: 319-323, 1981 (Pubitemid 11179328)
3. National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973-2007), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission. http://www.seer.cancer.gov
4. Gray RJ: A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16: 1141-1154, 1988
5. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509, 1999
6. Harrell FE: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer, 2001
7. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387, 1996 (Pubitemid 26072233)
8. Wolbers M, Koller MT, Witteman JC, et al: Prognostic models with competing risks: Methods and application to coronary risk prediction. Epidemiology 20: 555-561, 2009
9. Putter H, Fiocco M, Geskus RB: Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 26: 2389-2430, 2007 (Pubitemid 46730255)
10. R Development Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2011. http://www.R-project.org/
11. Gray B: cmprsk: Subdistribution Analysis of Competing Risks. R package version 2.2-2. http:// CRAN.R-project.org/package-cmprsk
12. Iasonos A, Schrag D, Raj GV, et al: How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26: 1364-1370, 2008
13. Hay ID, Grant CS, Taylor WF, et al: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102: 1088-1095, 1987 (Pubitemid 18010757)
14. Hay ID, Bergstralh EJ, Goellner JR, et al: Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1057, 1993
15. Cady B, Rossi R: An expanded view of riskgroup definition in differentiated thyroid carcinoma. Surgery 104: 947-953, 1988 (Pubitemid 19011971)
16. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al: Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol 25: 4952-4960, 2007 (Pubitemid 350220427)
17. Porter CR, Suardi N, Capitanio U, et al: A nomogram predicting prostate cancer-specific mortality after radical prostatectomy. Urol Int 84:132- 140, 2010
18. Stephenson AJ, Kattan MW, Eastham JA, et al: Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 27: 4300-4305, 2009
19. Lughezzani G, Sun M, Budäus L, et al: Population-based external validation of a competingrisks nomogram for patients with localized renal cell carcinoma. J Clin Oncol 28:e299-e300, 2010
20. Kutikov A, Egleston BL, Wong YN, et al: Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 28: 311-317, 2010
21. Gilliland FD, Hunt WC, Morris DM, et al: Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79: 564-573, 1997 (Pubitemid 27051783)
22. Kircher T, Nelson J, Burdo H: The autopsy as a measure of accuracy of the death certificate. N Engl J Med 313: 1263-1269, 1985 (Pubitemid 16217049)
23. Beyersmann J, Schumacher M, Allignol A: Competing Risks and Multistate Models with R (Use R!). New York, NY, Springer Science-Business Media, 2012
24. Sanabria A, Domínguez LC, Vega V, et al: Prognosis of patients with thyroid cancer who do not undergo surgical treatment: A SEER database analysis. Clin Transl Oncol 13: 692-696, 2011